Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormones and Bone Tissue01:17

Hormones and Bone Tissue

3.3K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.3K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

3.5K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.5K
Bone Remodeling01:40

Bone Remodeling

39.4K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
39.4K
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

7.3K
Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
7.3K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

8.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
8.5K
Bone Formation by Intramembranous Ossification01:29

Bone Formation by Intramembranous Ossification

9.2K
Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
9.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Osteoblast-Derived Osteomodulin Suppresses Bone Loss in Osteoporosis by Inhibiting Osteoclastogenesis.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

[Analysis of the Characteristics of the Oral Virome in Metabolic Dysfunction-Associated Fatty Liver Disease].

Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition·2026
Same author

Supragingival <i>Actinomyces naeslundii</i> aggravates metabolic dysfunction-associated fatty liver disease via the oral-gut axis.

Journal of oral microbiology·2026
Same author

Correction: Osteomodulin positively regulates osteogenesis through interaction with BMP2.

Cell death & disease·2026
Same author

Expert consensus on the treatment of oral diseases in pregnant women and infants.

International journal of oral science·2025
Same author

Expert consensus on management of instrument separation in root canal therapy.

International journal of oral science·2025

Related Experiment Video

Updated: Nov 18, 2025

Covalent Binding of BMP-2 on Surfaces Using a Self-assembled Monolayer Approach
10:23

Covalent Binding of BMP-2 on Surfaces Using a Self-assembled Monolayer Approach

Published on: August 26, 2013

14.3K

Osteomodulin positively regulates osteogenesis through interaction with BMP2.

Wenzhen Lin1,2,3, Xiaohan Zhu1,2,3, Li Gao4,5

  • 1Department of Endodontics, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Cell Death & Disease
|February 5, 2021
PubMed
Summary

Osteomodulin (OMD) promotes bone formation by enhancing BMP2 signaling. This study shows OMD is crucial for osteogenesis and bone regeneration, highlighting its therapeutic potential.

More Related Videos

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
11:20

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry

Published on: March 29, 2018

7.9K
Culture of Murine Embryonic Metatarsals: A Physiological Model of Endochondral Ossification
07:23

Culture of Murine Embryonic Metatarsals: A Physiological Model of Endochondral Ossification

Published on: December 3, 2016

12.2K

Related Experiment Videos

Last Updated: Nov 18, 2025

Covalent Binding of BMP-2 on Surfaces Using a Self-assembled Monolayer Approach
10:23

Covalent Binding of BMP-2 on Surfaces Using a Self-assembled Monolayer Approach

Published on: August 26, 2013

14.3K
Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
11:20

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry

Published on: March 29, 2018

7.9K
Culture of Murine Embryonic Metatarsals: A Physiological Model of Endochondral Ossification
07:23

Culture of Murine Embryonic Metatarsals: A Physiological Model of Endochondral Ossification

Published on: December 3, 2016

12.2K

Area of Science:

  • Biochemistry
  • Cell Biology
  • Regenerative Medicine

Background:

  • Osteomodulin (OMD) is a small leucine-rich proteoglycan found in mineralized tissues.
  • Its precise role in bone formation and interaction with bone morphogenetic protein 2 (BMP2) is not fully understood.

Purpose of the Study:

  • To investigate the function of Osteomodulin (OMD) in osteogenesis and its relationship with BMP2 signaling.
  • To explore OMD's potential in bone defect repair.

Main Methods:

  • Investigated OMD expression in human dental pulp stem cells during osteogenesis.
  • Utilized gene silencing and in vitro assays to assess OMD's effects on osteogenic markers.
  • Evaluated OMD and BMP2 combination therapy in a rat mandibular bone defect model.

Main Results:

  • Silencing OMD significantly inhibited alkaline phosphatase activity, mineralized nodule formation, and osteogenic gene expression.
  • OMD enhanced BMP2-induced expression of SP7 and RUNX2 in a dose-dependent manner.
  • Combined OMD and suboptimal BMP2 treatment in vivo resulted in more mature and abundant mineralized bone compared to single treatments.

Conclusions:

  • Osteomodulin (OMD) plays a critical role in promoting osteogenesis and bone mineralization.
  • OMD enhances BMP2/SMAD signaling by binding BMP2 and facilitating receptor complex formation.
  • OMD is a potential therapeutic target for enhancing bone regeneration and treating bone defects.